Scanning Electron Microscope: A New Potential Tool to Replace Gram Staining for Microbe Identification in Blood Cultures.

MALDI-TOF blood culture gram microbe identification rapid test scanning electron microscopy

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
28 May 2021
Historique:
received: 16 05 2021
revised: 25 05 2021
accepted: 26 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Blood culture is currently the most commonly used method for diagnosing sepsis and bloodstream infections. However, the long turn-around-time to achieve microbe identification remains a major concern for clinical microbiology laboratories. Gram staining for preliminary identification remains the gold standard. We developed a new rapid strategy using a tabletop scanning electron microscope (SEM) and compared its performance with Gram staining for the detection of micro-organisms and preliminary identification directly from blood cultures. We first optimised the sample preparation for twelve samples simultaneously, saving time on imaging. In this work, SEM proved its ability to identify bacteria and yeasts in morphotypes up to the genus level in some cases. We blindly tested 1075 blood cultures and compared our results to the Gram staining preliminary identification, with MALDI-TOF/MS as a reference. This method presents major advantages such as a fast microbe identification, within an hour of the blood culture being detected positive, low preparation costs, and data traceability. This SEM identification strategy can be developed into an automated assay from the sample preparation, micrograph acquisition, and identification process. This strategy could revolutionise urgent microbiological diagnosis of infectious diseases.

Identifiants

pubmed: 34071713
pii: microorganisms9061170
doi: 10.3390/microorganisms9061170
pmc: PMC8227564
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fondation Méditerranée Infection
ID : ANR-10-IAHU-03

Références

PLoS One. 2019 Sep 26;14(9):e0223122
pubmed: 31557233
Rinsho Byori. 2010 May;58(5):498-507
pubmed: 20560459
Ann Lab Med. 2014 Mar;34(2):111-7
pubmed: 24624346
Clin Microbiol Infect. 2018 Sep;24(9):944-955
pubmed: 29787889
Rinsho Byori. 2010 May;58(5):490-7
pubmed: 20560458
Front Microbiol. 2020 Nov 19;11:596180
pubmed: 33329483
J Bacteriol. 1990 Mar;172(3):1609-20
pubmed: 1689718
J Appl Lab Med. 2019 Jan;3(4):686-697
pubmed: 31639736
J Clin Microbiol. 2016 Oct;54(10):2455-63
pubmed: 27487951
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
Clin Microbiol Rev. 2018 May 30;31(3):
pubmed: 29848775
J Clin Microbiol. 1996 Aug;34(8):2051
pubmed: 8818915
J Infect. 2012 Dec;65(6):513-20
pubmed: 22940580
Expert Rev Mol Diagn. 2016;16(1):97-111
pubmed: 26559655
Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):33-8
pubmed: 10706177
J Clin Microbiol. 2013 Jun;51(6):1658-65
pubmed: 23515547
Pol Arch Intern Med. 2017 Feb 28;127(2):122-124
pubmed: 28267135
APMIS. 1995 Jan;103(1):37-44
pubmed: 7695890
Cells. 2020 Aug 13;9(8):
pubmed: 32823780
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
PLoS One. 2011;6(8):e23285
pubmed: 21858058
J Infect Chemother. 2016 Oct;22(10):697-703
pubmed: 27581389
J Clin Microbiol. 2007 Apr;45(4):1113-7
pubmed: 17301283
Clin Microbiol Infect. 2016 Mar;22(3):236-43
pubmed: 26577142
J Clin Microbiol. 2014 Apr;52(4):1242-5
pubmed: 24478405
PLoS One. 2016 May 26;11(5):e0156299
pubmed: 27228001
Int J Antimicrob Agents. 2009;34 Suppl 4:S13-5
pubmed: 19931809
Expert Rev Mol Diagn. 2019 Feb;19(2):161-173
pubmed: 30640566
J Antimicrob Chemother. 2006 Feb;57(2):326-30
pubmed: 16387751
Am J Clin Pathol. 2008 Dec;130(6):870-6
pubmed: 19019762
J Food Drug Anal. 2019 Apr;27(2):404-414
pubmed: 30987712
Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):405-13
pubmed: 25252627
Front Microbiol. 2021 Jun 16;12:658322
pubmed: 34220746
Postgrad Med. 2018 Jan;130(1):105-110
pubmed: 29091518

Auteurs

Gabriel Haddad (G)

Institut Hospitalo-Universitaire Méditerranée Infection 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Aix-Marseille Université, IRD, APHM, MEPHI, 27 Boulevard Jean Moulin, 13005 Marseille, France.

Sara Bellali (S)

Institut Hospitalo-Universitaire Méditerranée Infection 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Tatsuki Takakura (T)

Hitachi High-Tech Corporation, Analytical & Medical Solution Business Group, 882 Ichige, Hitachinaka-shi, Ibaraki 312-8504, Japan.

Anthony Fontanini (A)

Institut Hospitalo-Universitaire Méditerranée Infection 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Yusuke Ominami (Y)

Hitachi High-Tech Corporation, Nanotechnology Solutions Business Group, Toranomon Hills Business Tower, 1-17-1 Toranomon, Minato-ku, Tokyo 105-6409, Japan.

Jacques Bou Khalil (J)

Institut Hospitalo-Universitaire Méditerranée Infection 19-21 Boulevard Jean Moulin, 13005 Marseille, France.

Didier Raoult (D)

Institut Hospitalo-Universitaire Méditerranée Infection 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Aix-Marseille Université, IRD, APHM, MEPHI, 27 Boulevard Jean Moulin, 13005 Marseille, France.

Classifications MeSH